I. Çelik

A. Alkan, H. Turna, E. Esin, 2019, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study

A. Alkan, H. Turna, E. Esin, 2018, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

VB‐CHEP chemotherapy regimen for aggressive non‐Hodgkin's lymphomas

Y. Ozisik, N. Güler, Ö. Özyılkan, 1998, European journal of haematology.

Treatment of advanced refractory sarcomas with ifosfamide and etoposide combination chemotherapy.

Y. Ozisik, I. Barista, I. Çelik, 1998, Cancer investigation.

Biochemical markers of bone turnover in the diagnosis of myeloma bone disease

U. Kalyoncu, O. Karadag, O. Dizdar, 2005 .

Circulating and Local Bone Marrow Renin-angiotensin System in Leukemic Hematopoiesis: Preliminary Evidences

H. Abalı, D. Özatlı, I. Çelik, 2002, Hematology.

Increased soluble FAS suggests delayed apoptosis in familial Mediterranean fever complicated with amyloidosis.

E. Atalar, I. Haznedaroglu, Ş. Kirazlı, 2003, The Journal of rheumatology.

Improved Anti‐Emetic Efficacy of 5‐HT3 Receptor Antagonists in Cancer Patients with Genetic Polymorphisms of ABCB1 (MDR1) Drug Transporter

U. Yasar, M. Babaoğlu, A. Bozkurt, 2015, Basic & clinical pharmacology & toxicology.

Association of the ABCB1 3435C>T polymorphism with antiemetic efficacy of 5‐hydroxytryptamine type 3 antagonists

M. Babaoğlu, A. Aynacioglu, R. Kerb, 2005, Clinical pharmacology and therapeutics.

Biochemical markers of bone turnover in diagnosis of myeloma bone disease

U. Kalyoncu, O. Karadag, O. Dizdar, 2007, American journal of hematology.

Pathologic thrombopoiesis of rheumatoid arthritis

I. Haznedaroglu, S. Kiraz, I. Ertenli, 2003, Rheumatology International.

Bloodstream Thrombopoietin in Rheumatoid Arthritis with Thrombocytosis

Ş. Kirazlı, S. Kiraz, I. Ertenli, 2002, Clinical Rheumatology.

Granulocyte-Colony Stimulating Factor (G-CSF) Administration for Chemotherapy-Induced Neutropenia.

E. Kansu, N. Güler, I. Ertenli, 1996, Hematology.

Cytokines affecting megakaryocytopoiesis in rheumatoid arthritis with thrombocytosis

Ş. Kirazlı, S. Kiraz, I. Ertenli, 2005, Rheumatology International.

Pathological haemostasis and "prothrombotic state" in Behçet's disease.

I. Haznedaroglu, S. Kiraz, I. Ertenli, 2002, Thrombosis research.

Dihydropyrimidine Dehydrogenase Enzyme Deficiency: Clinical and Genetic Assessment of Prevalence in Turkish Cancer Patients

D. Guc, I. Çelik, A. Kars, 2002, Cancer investigation.

Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever.

M. Arıcı, Ş. Kirazlı, S. Pay, 1998, Clinical and experimental rheumatology.

A Retrospective Study of 137 Dysplastic Nevi: Are a Personal History of Melanoma and Histopathological Factors Associated with High-grade Cytologic Atypia?

S. Karahan, A. Kayıkçıoğlu, I. Çelik, 2015 .

Cyclophosphamide-Associated Carcinoma of the Urinary Bladder in Behçet’s Disease

M. Erman, I. Çelik, E. Baltalı, 1999, Nephron.

Coagulation, fibrinolysis and fibrinolysis inhibitors in haemodialysis patients: contribution of arteriovenous fistula.

Ç. Turgan, U. Yasavul, Ş. Çaǵlar, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Phase II trial of MINE as a front-line therapeutic modality in intermediate- and high-grade non-Hodgkin's lymphomas.

M. Hayran, N. Güler, O. Ozyılkan, 1998, European journal of cancer.

P-selectin as a circulating molecular marker in rheumatoid arthritis with thrombocytosis.

M. Arıcı, Ş. Kirazlı, S. Kiraz, 1998, The Journal of rheumatology.

Human immunodeficiency virus negative Kaposi sarcoma and lymphoproliferative disorders

I. Çelik, M. Kadri Altundağ, 2000, Cancer.

Clinical significance of hemostatic markers and thrombomodulin in systemic lupus erythematosus: evidence for a prothrombotic state

S. Kiraz, I. Ertenli, M. Calguneri, 1999, Lupus.

Coagulation and Fibrinolysis in Amyloid and Non-amyloid Hemodialysis Patients: Assessment of Local Hemostatic Kinetics Within Arteriovenous Fistulas

Ç. Turgan, Şali Çağlar, Ş. Kirazlı, 1996 .

Interactions of nitric oxide and superoxide dismutase in Behçet's disease.

B. Altun, S. Kiraz, M. Erman, 2001, Clinical and experimental rheumatology.

Ifosfamide-based chemotherapy for recurrent or metastatic hemangiopericytoma.

I. Barista, I. Çelik, İ. Güllü, 1997, Acta oncologica.

Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behçet's disease.

S. Kiraz, M. Erman, I. Ertenli, 1996, Dermatology.

Treatment of classical Kaposi's sarcoma with visceral involvement by weekly paclitaxel.

H. Engin, I. Çelik, 2002, Clinical oncology (Royal College of Radiologists (Great Britain)).

Intrathecal chemotherapy and bone marrow

I. Barista, I. Çelik, İ. Güllü, 1997, Leukemia.

Severe hyponatremia due to SIADH provoked by acute intermittent porphyria.

B. Altun, Ç. Turgan, U. Yasavul, 1996, Clinical nephrology.

The role of ABO blood groups in glial neoplasms

A. Alkan, F. Zorlu, M. Cengiz, 2016, British journal of neurosurgery.

Analysis of menstrual, reproductive, and life-style factors for breast cancer risk in Turkish women

N. Zengi̇n, F. Demirkazık, M. Erman, 2004, Medical oncology.

Cutaneous melanoma in Turkey: analysis of 1157 patients in the Melanoma Turkish Study.

H. Harputluoglu, B. Karaca, O. Er, 2015, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Behçet's disease. A randomized clinical trial.

S. Kiraz, I. Ertenli, M. Calguneri, 1996, Arthritis and rheumatism.

Hyalinizing trabecular adenoma of thyroid masquerading as thyroid carcinoma.

M. Benekli, I. Çelik, A. Kars, 1997, Acta oncologica.

Synovial fluid cytokine levels in Behçet's disease.

Ş. Kirazlı, S. Kiraz, M. Erman, 2001, Clinical and experimental rheumatology.

Plasminogen activator inhibitor-1 as a link between pathological fibrinolysis and arthritis of Behçet's disease

I. Haznedaroglu, Ş. Kirazlı, S. Kiraz, 2004, Rheumatology International.

Characteristics of peripheral arthritis in Behçet's disease.

S. Kiraz, M. Erman, I. Ertenli, 1997, The New Zealand medical journal.

Behçet disease: advantageous against development of neoplasia?

E. Kansu, S. Kiraz, I. Barista, 1996, Annals of the Rheumatic Diseases.

Haemostasis, Thrombosis, and Endothelium in Behcet's Disease

I. Haznedaroglu, Ş. Kirazlı, A. Kosar, 1998, Acta Haematologica.

Changes in the concentration and distribution of tissue factor pathway inhibitor in Behçet's disease and systemic lupus erythematosus: effect on the prethrombotic state

Ş. Kirazlı, S. Kiraz, M. Erman, 2001, Annals of the rheumatic diseases.

Tropisetron, Ondansetron, and Granisetron for Control of Chemotherapy-Induced Emesis in Turkish Cancer Patients: A Comparison of Efficacy, Side-Effect Profile, and Cost

H. Abalı, I. Çelik, 2007, Cancer investigation.

Timing of therapy in vasculitis-associated multiple myeloma: comment on the article by Hasegawa et al.

E. Kansu, A. Topeli, I. Barista, 1997, Arthritis and rheumatism.

Bilateral Seqential Acral Lentiginous Melanoma of the Sole

S. Kars, I. Çelik, O. Keskin, 2013 .

Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy

M. Dogan, O. Yazıcı, A. Ozet, 2021, Future oncology.

Procarbazine, CCNU, vincristine combination in the treatment of brain tumors.

E. Kansu, N. Güler, M. Altunbas, 1996, Tumori.

Maintenance therapy with alpha‐interferon following first‐line VAD in multiple myeloma

N. Zengi̇n, E. Kansu, M. Hayran, 1997, European Journal of Haematology.

Modified ESHAP as Salvage Chemotherapy for Recurrent or Refractory Non-Hodgkin’s Lymphoma: Results of a Single-Center Study of 32 Patients

E. Kansu, N. Güler, I. Barista, 2002, Chemotherapy.

Primary central nervous system lymphoma presenting with multiple myeloma-like clinical picture

I. Barista, I. Çelik, İ. Güllü, 1997, Journal of neurology, neurosurgery, and psychiatry.

Erectile dysfunction in successfully treated lymphoma patients

H. Harputluoglu, O. Dizdar, H. Ozen, 2008, Supportive Care in Cancer.

Cytarabine-induced fever complicating the clinical course of leukemia

I. Haznedaroglu, C. Gonen, Y. Cetinkaya, 2005, Anti-cancer drugs.

Isolated hyperbilirubinemia following standard dose cytosine arabinoside in a patient with relapsed acute myeloid leukemia

O. Altundag, I. Çelik, A. Kars, 2004, American journal of hematology.

Plasma fibronectin- and thrombospondin-adhesive molecules during acute attacks and attack-free periods of familial Mediterranean fever

Ş. Kirazlı, S. Kiraz, I. Ertenli, 2001, Rheumatology International.

Solitary phalanx plasmacytoma relapse with disseminated extramedullary plasmacytomas and myeloma after short duration of remission.

E. Kansu, I. Barista, I. Çelik, 1996, Anticancer research.

Ifosfamide, mesna and epirubicin as second-line chemotherapy in advanced breast cancer.

N. Güler, S. Kiraz, M. Benekli, 1996, Journal of chemotherapy.

Factors influencing the distribution of metastases and survival in metastatic breast carcinoma.

Y. Ozisik, N. Güler, O. Saraçbaşi, 1996, American journal of clinical oncology.

Clinical features and outcomes of COVID‐19 in patients with solid tumors: Turkish National Registry Data

O. Yazıcı, M. Hayran, M. Erman, 2020, International journal of cancer.

Ifosfamide and Etoposide in Previously Treated Patients with Advanced Breast Cancer

N. Güler, S. Kiraz, M. Benekli, 1997, Tumori.

Agranulocytosis, Plasmacytosis, and Thrombocytosis Followed by a Leukemoid Reaction Due to Acute Acetaminophen Toxicity

I. Haznedaroglu, N. Sayınalp, S. Dündar, 1996, The Annals of pharmacotherapy.

FREQUENCY OF CANCER TYPES IN PATIENTS AGED 65 AND OLDER: RESULTS FROM CANCER REGISTRY DATABASE OF HACETTEPE UNIVERSITY HOSPITALS

K. Hayran, M. Erman, T. Kutluk, 2011 .

Neoadjuvant Chemotherapy with Taxotere-Epirubicin-5-Fluorouracil (TEF) in Local-Regionally Advanced Breast Cancer: A Preliminary Report

O. Abbasoğlu, N. Güler, I. Çelik, 2002, Tumori.

Is there a range of time for initiation of adjuvant chemotherapy in patients with malignancy?

Y. Ozisik, I. Çelik, M. Altundağ, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Recurrent Asymptomatic Bradycardia Episodes after Cisplatin Infusion

I. Çelik, A. Kars, Ö. Altundağ, 2001, The Annals of pharmacotherapy.

Renal Cell Carcinoma Presenting as Solitary Cervical Node Metastasis Compressing the Brachial Plexus

M. Benekli, I. Çelik, İ. Güllü, 1998, Nephron.

High-dose ifosfamide by infusion with Mesna in advanced refractory sarcomas.

N. Zengi̇n, N. Güler, I. Barista, 1996, Cancer investigation.

Portal vein thrombosis in cirrhotics: related with anticardiolipin antibodies?

Y. Bayraktar, Ş. Kirazlı, B. Sivri, 2003, Hepato-gastroenterology.

Clinical Features and Prognostic Factors of Hodgkin's Lymphoma: A Single Center Experience.

Y. Ozisik, F. Yıldız, S. Kılıçkap, 2013, Balkan medical journal.

High incidence of central nervous system involvement in patients with breast cancer treated with epirubicin and docetaxel.

H. Abalı, I. Çelik, 2002, American journal of clinical oncology.

Bevacizumab, bleeding, thrombosis, and warfarin. Author's reply

F. Kabbinavar, S. Cascinu, F. Graziano, 2003 .

Non-Hodgkin's Lymphomas of the Tonsil: A Retrospective Analysis of Twenty-Eight Patients with Primary Tonsillary Lymphoma

N. Güler, I. Barista, I. Çelik, 1995, Tumori.

A randomized Phase III trial of etoposide, epirubicin, and cisplatin versus 5‐fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma

F. Tas, M. Özgüroğlu, H. Akbulut, 1998 .

Persistent Hypercalcemia Leading to Acute Pancreatitis in a Patient with Relapsed Myeloma and Renal Failure

E. Kansu, N. Güler, I. Barista, 1998, Nephron.

Phenotypic and Genetic Features that Differ Between Hereditary and Sporadic Melanoma: Results of a Preliminary Study from a Single Center from Turkey

S. Kılıçkap, I. Çelik, G. Elçin, 2023, Dermatology practical & conceptual.

Increasing performance of a hospital-based cancer registry: Hacettepe University hospitals experience.

M. Erman, D. Yuce, T. Kutluk, 2013, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.